EP Plenary session - Oral question - COVID-19 – Sustaining EU preparedness and response: looking ahead

EP Plenary session - Joint Debate - European Health Union

COVI Special Committee - Exchange of views with Emily O’Reilly, European Ombudsman

COVI Special Committee - lessons learned and recommendations for the future - Exchange of views with Professor Alexandru Rafila, Romanian Minister of  Health

COVI Special Committee - lessons learned and recommendations for.the future - Exchange of views with Sandra Gallina, Director-General for Health and Food Safety, European Commission

COVI Special Committee - Exchange of views with the European Centre for Disease Prevention and Control (ECDC) and Health Emergency Preparedness and Response Authority (HERA) on COVID-19 pandemic

COVI Special Committee - Exchange of views with European Centre for Disease Prevention and Control (ECDC) and Health Emergency Preparedness and Response Authority (HERA) on COVID-19 pandemic

ENVI Committee - Presentation of the Czech  Presidency of the Europen Council’s programme.- Exchange of views with Mr Vlastimil Válek, Czech Minister of Health

EP Plenary session - Towards a common European action on care

ENVI Committee - Exchange of views with Ms Stella Kyriakides, Commissioner for Health and Food Safety

Special Committee on the COVID-19 pandemic: lessons learned and recommendations for the future

ENVI Committee - Exchange of views with the European Centre for Disease Prevention and Control (ECDC) on the outbreak of monkeypox

During the plenary session (14-17 September 2020) in Brussels, MEPs debate on the Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market. First round of political group leaders.

Covid-19: EU coordination of health assessments and risk classification and the consequences on Schengen and the single market: First round of political group leaders

During the plenary session (14-17 September 2020) of the European Parliament in Brussels, MEPs debate the lack of coordination regarding COVID-19 health assessments and risk classification and its consequences for the Schengen area. They are set to call for a common EU approach.

Covid-19 - EU coordination of health assessments and risk classification and the consequences on Schengen: extracts from the debate

Following a presentation by the Commission on the status of COVID-19 vaccines, the Committee on Environment and Public Health (ENVI) debate with Sandra GALLINA, Deputy Director General of Health and Food safety (European Commission) on how to ensure equitable access to affordable and safe COVID-19 vaccines everywhere, for everyone who needs them, in the Europena Parliament in Brussels.

EU vaccines strategy: extracts from the debate

During the plenary session of the European Parliament in Brussels (08-10 July 2020), MEPshave discussed on the EU’spublic health strategy to give a response amid the Covid-19 crisis, on 8th July. Statements by Michael ROTH, German Presidency, Stella KYRIAKIDES, European Commissioner for Health and Food Safety, Peter LIESE (EPP, DE), Heléne FRITZON (S&D, SE), Véronique TRILLET-LENOIR (RE, FR), and Petra DE SUTTER (Greens/EFA, BE). On 10th July, they voted : 526 in favor, 105 against and 50 abstention. Adopted.

EU’s public health strategy post-COVID-19: result of the final vote and extracts from the debate (08/07)

Members of the EP Committee on the Environment, Public Health and Food Safety (ENVI) debate with Hans KLUGE, WHO Regional Director for Europe, during an exchange of views on the fight against COVID-19 and the global response to it. Increased coordination and cooperation at global level are crucial to better prevent and tackle pandemics. MEPs debate - part 2 followed by the response by Hans KLUGE, WHO Regional Director for Europe

Exchange of views with Hans KLUGE, WHO Regional Director for Europe: MEPs debate (part 2) and response by Hans KLUGE

During the plenary session in the European Parliament in Brussels (13-16 May 2020), debate on vaccines and therapeutics in the context of Covid-19. First round political group leaders

Vaccines and therapeutics in the context of Covid-19: First round political group leaders

During the plenary session of the European Parliament in Brussels, MEPs debate with Council and Commission on boosting research to ensure everyone has swift access to future vaccines and treatments for the novel Coronavirus, Covid-19.

Vaccines and therapeutics in the context of Covid-19: extracts from the debate

Live Replay of the debate on Coronavirus outbreak, state of play and ensuring a coordinated European response to the health, economic and social impact during the plenary session in Brussels. The plenary session takes place in Brussels instead of Strasbourg because of concerns linked to the spread of the coronavirus. The session has been shortened to one day - Tuesday 10 March

Coronavirus outbreak, state of play and ensuring a coordinated European response to the health, economic and social impact: MEPs debate (part 1)

On 2nd October, Janez LENARČIČ, Commissioner-designate, Crisis Management, from Slovenia, is heard by the Committee on Development (DEVE) of the European Parliament in association with the Committee on the Environment, Public Health and Food safety (ENVI) in Brussels to test his general competences, European commitment and specific expertise related to his portfolio. Questions by the Political group coordinators and their representatives. Second round of questions

45 tulosta